Federation des caisses Desjardins du Quebec
PDSB icon

Federation des caisses Desjardins du Quebec’s PDS Biotechnology PDSB Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.4K Buy
19,800
+5,000
+34% +$5.31K ﹤0.01% 2230
2026
Q1 		$8.95K Hold
14,800
– – ﹤0.01% 2362
2025
Q4 		$11.4K Sell
14,800
-4,000
-21% -$3.61K ﹤0.01% 2213
2025
Q3 		$19K Hold
18,800
– – ﹤0.01% 2060
2025
Q2 		$25K Hold
18,800
– – ﹤0.01% 1748
2025
Q1 		$22.4K Buy
18,800
+5,000
+36% +$7.11K ﹤0.01% 1695
2024
Q4 		$22.5K Buy
13,800
+4,800
+53% +$12.7K ﹤0.01% 1644
2024
Q3 		$34.4K Hold
9,000
– – ﹤0.01% 1504
2024
Q2 		$26.4K Hold
9,000
– – ﹤0.01% 1539
2024
Q1 		$35.6K Buy
9,000
+4,000
+80% +$20.6K ﹤0.01% 1497
2023
Q4 		$24.9K Buy
+5,000
New +$24.9K ﹤0.01% 1510
2020
Q4 		– Sell
-25
Closed -$58 – 2371
2020
Q3 		$58 Buy
+25
New +$70 ﹤0.01% 2141

Other funds holding PDSB

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return
Quantinno Capital Management
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
MCM
Militia Capital Management Austin, Texas $3.37B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's PDSB Position: Q2 2026 in Review

Federation des caisses Desjardins du Quebec increased its PDS Biotechnology (PDSB) stake by 34% in Q2 2026, buying an estimated $5.31K and bringing the position to 19,800 shares worth $17.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2230.

Federation des caisses Desjardins du Quebec first reported a position in PDSB in Q3 2020 and has held it in 12 quarters since. The position peaked at $35.6K in Q1 2024. 52 funds tracked by Wall St. Rank hold PDSB as of Q2 2026.

  • Federation des caisses Desjardins du Quebec held 19,800 shares of PDS Biotechnology worth $17.4K as of Q2 2026.
  • Federation des caisses Desjardins du Quebec bought 5,000 PDS Biotechnology shares in Q2 2026, an estimated $5.31K.
  • PDS Biotechnology made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q2 2026, its #2230 holding.
  • Federation des caisses Desjardins du Quebec first reported a position in PDS Biotechnology in Q3 2020 and has held it in 12 quarters since.
  • Federation des caisses Desjardins du Quebec's PDS Biotechnology position peaked at $35.6K in Q1 2024.
  • 52 funds tracked by Wall St. Rank held PDS Biotechnology as of Q2 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.